MedTrace Logo

Development of Biomarkers of Effect From Chronic Tobacco Usage

NCT01923402 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2016-02-19

No results posted yet for this study

Summary

This study was conducted to develop biomarkers of tobacco effect that would indicate potential harm related to tobacco consumption. To gain a better understanding of chronic effects of tobacco consumption, this cross-sectional clinical study enrolled generally healthy, adult male consumers of cigarettes (SMK), moist snuff (MSC), and no tobacco products (NTC).

Conditions

  • Cigarette Smoking

Sponsors & Collaborators

  • R.J. Reynolds Tobacco Company

    lead INDUSTRY

Principal Investigators

  • Melanie Fein, MD · Mendenhall Clinical Research Center

Eligibility

Min Age
35 Years
Max Age
60 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-06-30
Primary Completion
2011-01-31
Completion
2011-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01923402 on ClinicalTrials.gov